| Drossapharm AG - Atorvastax-Drossapharm 40 mg, Filmtabletten | | 70323 | | 03 | | Atorvastax-Drossapharm 40 mg | | Filmtabletten | | C10AA05 | | Atorvastatin | | 03.09.2026 | | |
| | Composition | | atorvastatinum 40 mg ut atorvastatinum calcicum, cellulosum microcristallinum, calcii carbonas, maltosum, carmellosum natricum conexum corresp. natrium max. 1.62 mg, polysorbatum 80, magnesii aluminometasilicas, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, polysorbatum 80, E 171, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Atorvastatine | 40 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Calcium Carbonate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Magnesii Aluminometasilicas | | | | Magnesii Stearas | | | | Maltosum | | | | Polysorbatum 80 | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 30 | | | B | | Oui | | 006 | 100 | | | B | | Oui |
|
|
